Flo Health Raises $200 Million

Women’s health tech, which leverages innovations in AI, smartphones and connected wearables to give women more insights into reproductive and menstrual health, continues to gain momentum with users, and investors are following. London-based Flo Health, a fertility-focused period-tracking app, said it has raised a $200 million Series C from General Atlantic. The funding values the startup at more than $1 billion post-money, which, per the company, makes it the first “purely digital” women’s health app to become a unicorn. That distinction is challenging to qualify, since it seems that there are no clear “purely digital” unicorns in the women’s health category for comparison. (Maven, which describes itself as a health clinic and benefits platform, was last valued at $1.33 billion in 2022.) The fundraise comes after an impressive run of growth, which is notable considering the bumps Flo has faced, including one around a now-settled, privacy-related regulatory investigation from the Federal Trade Commission, and the generally bearish state of the technology market. The company says it has served some 380 million users globally so far, and it currently has 70 million monthly active users of its free product, and another 5 million who are paying for the premium version. The funding will be used both to attract more users, as well as to appeal to older users with a focus on menopause and perimenopause. The startup may also look to make acquisitions to grow inorganically, potentially with more support from General Atlantic.